The domestic production, sales and market share of raw materials such as levofluoride hydrochloride and cyclopropyl hydrochloride are among the best, and their products sell well in international markets such as Southeast Asia, South Asia, Latin America and Europe. Raw materials and preparations of rosuvastatin calcium have been produced on a large scale.
The company has postdoctoral research center, Zhejiang Enterprise Research Institute and provincial technical center, and cooperates with many national medical research institutions and famous universities. It has strong scientific research and technical strength, and has achieved fruitful research and development results. It owns 7 national key new products and undertakes 7 national torch plan projects, and sertraline hydrochloride is rated as a national biomedical high-tech industry demonstration project.
With the quality concept of "Beijing new drug, carefully manufactured", the company passed the German GMP certification, 201new GMP certification and 20 12 German (EU) GMP re-certification for the first time in 2006. Simvastatin and ciprofloxacin hydrochloride also obtained COS certificates, ciprofloxacin hydrochloride also passed EDQM on-site inspection and obtained French GMP certificates.
In 2008, simvastatin tablets were exported to the UK for the first time, which opened the export of finished chemicals from China to the UK high-end market. In 2009, the company achieved the goal of exporting finished drugs to Germany. In 20 12, the export of pharmaceutical preparations further explored the European market, and the growth momentum was rapid. The company was also listed as "excellent enterprise brand of China pharmaceutical industry" and "leading enterprise of pharmaceutical internationalization in China".
With the core business philosophy of "building an excellent enterprise and building a new brand in Beijing", the company's comprehensive economic benefits have been rapidly improved. Since 20 10, the company has been listed among the top 100 chemical and pharmaceutical enterprises in China, and has successively won the titles of "AAA enterprise with abiding by contracts and keeping credit in Zhejiang province", "AAA enterprise with tax credit rating in Zhejiang province", "Zhejiang patent demonstration enterprise" and "outstanding innovative enterprise in Zhejiang province".